UPDATE: DeCode and Genmab Collaborate on Antibody Development and Diagnostics

Jun 12, 2001

NEW YORK, June 12 - DeCode Genetics and Genmab said Tuesday they would collaborate in developing antibodies against DeCode's gene-based drug targets associated with cancer, cardiovascular, and inflammatory diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Mouse Fight

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Seeing the Interactions

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

This Week in Science

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

For Millions

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Main menu